Income from operations for Q4FY26 rose 2% year-on-year to Rs 10,511 crore, in contrast with Rs 10,293 crore within the corresponding quarter of the earlier monetary 12 months.
Whole earnings through the quarter elevated 3% to Rs 10,595 crore from Rs 10,304 crore a 12 months in the past. Different earnings stood at Rs 84 crore, considerably increased than Rs 11 crore reported within the year-ago quarter.
Earnings earlier than curiosity, taxes, depreciation and amortisation, or EBITDA, rose 9% year-on-year to Rs 493 crore within the reported quarter.
Dixon Tech shares: Must you purchase, promote or maintain?
Brokerage agency Goldman Sachs has maintained a “Promote” score on Dixon Applied sciences and revised its goal worth to Rs 9,790 from Rs 9,985 earlier (3.4% draw back). The brokerage mentioned the corporate’s This fall outcomes missed estimates primarily resulting from weaker efficiency within the cellular and EMS segments, though EBITDA margin at 3.9% remained broadly in step with expectations. Goldman Sachs famous that elevated DRAM costs proceed to weigh on cell phone volumes and expects the FY27 outlook for the cellular enterprise to stay subdued. The brokerage additionally cautioned that the absence of PLI incentives may strain margins additional and mentioned the earnings downgrade cycle might proceed. Nonetheless, it added that the rollout of PLI 2.0 may emerge as a near-term constructive set off for the inventory.
Sensex, Nifty at the moment: Catch all of the LIVE inventory market motion right here
Motilal Oswal has additionally maintained a “Purchase” score on Dixon Applied sciences with a goal worth of Rs 14,600, indicating an upside potential of 44%. The brokerage mentioned it has barely revised its FY27 and FY28 estimates to think about decrease volumes and margins, although increased smartphone realisations are anticipated to offer help. It now expects the corporate to ship a CAGR of 33% in income, 37% in EBITDA and 36% in revenue after tax between FY26 and FY28. The brokerage additional mentioned EBITDA margin is projected at 3.3% in FY27 and is probably going to enhance to 4.1% in FY28 as backward integration initiatives start contributing following the PLI scheme.JM Monetary has maintained an “Add” score on Dixon Applied sciences with a goal worth of Rs 11,200, implying an upside potential of 10.5%. The analysts cautioned that elevated chip costs may weigh on smartphone demand and prohibit natural smartphone quantity progress in FY27. Excluding Vivo, the corporate has guided for flat smartphone volumes in FY27, whereas the best-case situation could be double-digit progress if the PLI 2.0 scheme materialises and meaningfully boosts exports inside the 12 months. The brokerage added {that a} attainable 12-15% rise in smartphone common promoting costs may partly offset strain on revenues, though it believes even flat volumes in FY27 might show optimistic beneath present circumstances.
(Disclaimer: Suggestions, ideas, views and opinions given by the consultants are their very own. These don’t symbolize the views of The Financial Instances)
